Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery
Authors
Keywords
Recurrence, Colorectal cancer, Systemic inflammatory response, Tumor-infiltrating lymphocyte, Microsatellite instability
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 60, Issue 8, Pages 2477-2487
Publisher
Springer Nature
Online
2015-04-04
DOI
10.1007/s10620-015-3648-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients
- (2014) Joanna Szkandera et al. AMERICAN JOURNAL OF SURGERY
- The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
- (2014) S Krenn-Pilko et al. BRITISH JOURNAL OF CANCER
- Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue
- (2013) Anna M. Sherwood et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer
- (2013) J.H. Park et al. CANCER TREATMENT REVIEWS
- Comment on Mallappaet al.: Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer
- (2013) S. G. Farid et al. Colorectal Disease
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor-Derived Chemokine CCL5 Enhances TGF- -Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
- (2012) L.-Y. Chang et al. CANCER RESEARCH
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?
- (2012) Sum-Fu Chiang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
- (2011) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
- (2011) Sylvain Ladoire et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
- (2011) C.S.D. Roxburgh et al. CANCER TREATMENT REVIEWS
- Microsatellite Instability, EMAST, and Morphology Associations with T Cell Infiltration in Colorectal Neoplasia
- (2011) Sun-Young Lee et al. DIGESTIVE DISEASES AND SCIENCES
- Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
- (2011) Bernhard Mlecnik et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
- (2011) Anna M Dahlin et al. MODERN PATHOLOGY
- Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
- (2010) Cecilia Guastadisegni et al. EUROPEAN JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer
- (2010) Pei-Rong Ding et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
- (2010) Pierpaolo Correale et al. JOURNAL OF IMMUNOTHERAPY
- An Optimized Pentaplex PCR for Detecting DNA Mismatch Repair-Deficient Colorectal Cancers
- (2010) Ajay Goel et al. PLoS One
- Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
- (2009) M. Camus et al. CANCER RESEARCH
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability
- (2008) S Michel et al. BRITISH JOURNAL OF CANCER
- MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells
- (2008) Kristi Baker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Local Recurrence in Mismatch Repair-Proficient Colon Cancer Predicted by an Infiltrative Tumor Border and Lack of CD8+ Tumor-Infiltrating Lymphocytes
- (2008) I. Zlobec et al. CLINICAL CANCER RESEARCH
- Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment
- (2008) M. Kornmann et al. EJSO
- Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
- (2008) Yvette Schwitalle et al. GASTROENTEROLOGY
- Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
- (2008) William M. Grady et al. GASTROENTEROLOGY
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started